Market cap is currently about $12 Million. I think that should now be considered cheap. If you were to look at this company as a clean slate, removing the past share price, r/s, leadership etc. this company would be bought in an instant for 3x to 4x its current market cap.
They have a great niche, great products that save time and money (and molecular diagnostics can save lives too).
Their growth numbers should prove to be stellar into the future as they ramp up with their current 4 panels.
Recurring sales model.
Now if an activist investor would just come in and give the company a fresh start and look into augmenting the leadership of...ok, I'll say it - Ashton LaDouche and Rona LaDiluter - GBSN would take off like a rocket.
